KEGG   DRUG: Bafisontamab
Entry
D12809                      Drug                                   
Name
Bafisontamab (USAN/INN)
Formula
C10544H16326N2794O3340S70
Exact mass
237767.4001
Mol weight
237913.84
Sequence
(A chain)
DIQMTQSPSS VSASVGDRVT ITCRASQGIN TWLAWYQQKP GKAPKLLIYA ASSLKSGVPS
RFSGSGSGTD FTLTISSLQP EDFATYYCQQ ANSFPLTFGG GTKVEIKRTV AAPSVFIFPP
SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGECQVQLQE SGPGLVKPSE TLSLTCTVSG
GSVSSGDYYW TWIRQSPGKG LEWIGHIYYS GNTNYNPSLK SRLTISIDTS KTQFSLKLSS
VTAADTAIYY CVRDRVTGAF DIWGQGTMVT VSSASTKGPS VFPLAPSSKS TSGGTAALGC
LVKDYFPEPV TVSWNSGALT SGVHTFPAVL QSSGLYSLSS VVTVPSSSLG TQTYICNVNH
KPSNTKVDKK VEPKSCDKTH TCPPCPAPEL LGGPSVFLFP PKPKDTLMIS RTPEVTCVVV
DVSHEDPEVK FNWYVDGVEV HNAKTKPREE QYNSTYRVVS VLTVLHQDWL NGKEYKCKVS
NKALPAPIEK TISKAKGQPR EPQVYTLPPS REEMTKNQVS LTCLVKGFYP SDIAVEWESN
GQPENNYKTT PPVLDSDGSF FLYSKLTVDK SRWQQGNVFS CSVMHEALHN HYTQKSLSLS
PGK
(B chain)
QVQLVQSGAE VKKPGASVKV SCKASGYTFT SYGFSWVRQA PGQGLEWMGW ISASNGNTYY
AQKLQGRVTM TTDTSTSTAY MELRSLRSDD TAVYYCARVY ADYADYWGQG TLVTVSSAST
KGPSVFPLAP SSKSTSGGTA ALGCLVKDYF PEPVTVSWNS GALTSGVHTF PAVLQSSGLY
SLSSVVTVPS SSLGTQTYIC NVNHKPSNTK VDKKVEPKSC
(C chain)
DIQMTQSPSS LSASVGDRVT ITCQASQDIS NYLNWYQQKP GKAPKLLIYD ASNLETGVPS
RFSGSGSGTD FTFTISSLQP EDIATYFCQH FDHLPLAFGG GTKVEIKRTV AAPSVFIFPP
SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
(Disulfide biridge: A23-A88, A134-A194, A214-B220, A236-A311, A360-A416, A436-C214, A442-A'442, A445-A'445, A477-A537, A583-A641, A'23-A'88, A'134-A'194, A'214-B'220, A'236-A'311, A'360-A'416, A'436-C'214, A'477-A'537, A'583-A'641, B22-B96, B144-B200, B'22-B'96, B'144-B'200, C23-C88, C134-C194, C'23-C'88, C'134-C'194)
  Type
Peptide
Efficacy
Antineoplastic, Immunomodulator
  Type
Monoclonal antibody, bispecific antibody
Target
MET [HSA:4233] [KO:K05099]
EGFR [HSA:1956] [KO:K04361]
  Pathway
hsa04010  MAPK signaling pathway
hsa04014  Ras signaling pathway
hsa04015  Rap1 signaling pathway
hsa04151  PI3K-Akt signaling pathway
hsa05200  Pathways in cancer
Brite
Target-based classification of drugs [BR:br08310]
 Protein kinases
  Receptor tyrosine kinases (RTK)
   EGFR family
    EGFR
     D12809  Bafisontamab (USAN/INN)
   MET family
    MET
     D12809  Bafisontamab (USAN/INN)
Other DBs
CAS: 2437210-79-0
PubChem: 497621222
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system